• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.23 Down 0.09(2.08%) 4:00PM EST
    |After Hours : 4.38 Up 0.15 (3.55%) 7:14PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.32
    Open:4.33
    Bid:4.39 x 500
    Ask:4.42 x 1200
    1y Target Est:6.90
    Beta:-4.12
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:4.20 - 4.40
    52wk Range:3.26 - 7.24
    Volume:4,454,736
    Avg Vol (3m):8,753,900
    Market Cap:931.87M
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 2.08%931.87M
    GSKDown 0.46%114.50B
    OREXDown 5.65%991.05M
    RHHBYDown 1.07%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.48
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback